Viewing Study NCT06692712

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 11:13 PM

Ignite Modification Date: 2025-12-26 @ 11:13 PM

Study NCT ID: NCT06692712

Status: NOT_YET_RECRUITING

Last Update Posted: 2024-11-18

First Post: 2024-11-14

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: Phase 3, Open-label Study to Assess the Efficacy and Safety of a Single Lumbar Intrathecal Administration of MELPIDA in Individuals with Hereditary Spastic Paraplegia Type 50 (SPG50) Versus Matched Prospective Concurrent Controls.

Sponsor: Elpida Therapeutics SPC

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module